Dr. Richard Whitley is a distinguished Professor of Pediatrics, Vice Chairman of the Department of Pediatrics and Co-Division Director of Pediatric Infectious Diseases at the University of Alabama at Birmingham School of Medicine. He also holds the titles of Loeb Eminent Scholar Chair in Pediatrics; Professor of Microbiology, Medicine, & Neurosurgery; Senior Scientist, Department of Gene Therapy; and Co-Founder and Co-Director, Alabama Drug Discovery Alliance.
Whitley is an expert on how antiviral therapies fight infections in children and adults. He is responsible for the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group that performs clinical trials of antiviral therapies against serious viral diseases in children and adults. Whitley’s other research interest is the translation of molecular biology to clinical application, particularly human monoclonal antibodies for therapy of herpesvirus infections and engineering of herpes simplex virus for gene therapy. He received his B.A. in chemistry from Duke University and his M.D. from the George Washington University.